Ivonescimab is the first therapy to achieve statistically significant positive results in a Phase III trial compared with ...

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure.

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and ...

The protein-like polymer, or PLP, platform is made from a polymer that mimics Nrf2. Once injected intravenously, it finds ...

Genomics company, Integrated DNA Technologies, is rewriting the future of genomics, pioneering new innovations in a bold move ...

Prostate cancer is the second-leading cause of cancer deaths among men in the United States and the rate of men diagnosed with advanced disease has been growing in recent years. 1 Veracyte estimates ...

The company anticipates submitting a biologics licence application for accelerated approval in the US in early 2026.

"Moreover, the duration of follow-up is among the longest reported for a lentiviral vector-based gene therapy; 13 patients ...

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of therapy. Upon FDA approval of an IND application, Siren plans to start on ...